Status and phase
Conditions
Treatments
About
Research Protocol Abstract:
This is a phase II controlled trial (RCT) of a "storytelling" intervention compared to no treatment among surrogates who have participated in a decision to limit life-sustaining treatment in the ICU for an incapacitated loved one. Subjects will be sequentially assigned to "storytelling" (a facilitated elicitation of the experience 2-4 weeks after bereavement) or no treatment with follow up "monitoring of well-being". Subjects will receive print bereavement brochures at 1 week, and undergo telephone symptom assessment at 2-weeks, 3-months, and 6-months after bereavement.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Screening/Re-contact (1st phase)
Eligible patients will:
Eligible surrogates will:
be 18 years of age or older
self-identify as having primary decision-making authority for the patient
live within approximately 50miles or less of the University of Pittsburgh
be able to conduct a 1hr interview in English
For Assignment to Intervention/Control (2nd phase)
Eligible surrogates will:
Exclusion criteria
Screening/Re-contact
Ineligible patients will:
Ineligible surrogates will:
For Assignment to Intervention/Control
Ineligible patients will:
Primary purpose
Allocation
Interventional model
Masking
115 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal